Health TrialsbyHealthPanel

Hospital @ Home Model of Care for Cirrhosis

ConditionDecompensated Cirrhosis
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorIndiana University

About this trial

The purpose of this study is to work with patients diagnosed with end-stage liver disease to understand their perspectives on the Health at Home (H@H) Program, including desired outcomes and expectations, perceived barriers, and drivers. H@H is an emerging model of home-based care, designed to extend traditional, inpatient hospital care which may address these needs. Through H@H, acute medical care services as well as ancillary care such as rehabilitation therapy can be delivered in the home. The study is divided into three phases: Phase 1 occurs while the participant is an inpatient. Phase 2 is when the actual H@H program takes place as part of the participant's clinical care. The study team will not be involved in the Phase 2 - H@H program as it will be conducted by the clinical staff. Phase 3, at which point the participant enters a rehabilitation phase to transition the patient to self-management, involves a research jam session with the participant and caregiver to assess the value of the program.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Enrolled into IUH's H@H program

At least 18 years of age

Chronic liver disease/cirrhosis based on characteristic clinical, laboratory, and imaging findings

English speaking

Disqualifiers

Unable to complete study questionnaires due to neurocognitive disease, legal blindness or hearing loss

Transplant of organ other than liver

Pregnant

Incarcerated

Trial design

Design model

Single group

Treatments tested in this trial

  • Indiana University Health Hospital at Home Program

    Other intervention

    Structure of Care in IUH H@H Program: The IUH H@H program allows patients to be cared for at home using home remote monitoring devices, travel laboratory services and both in-person and virtual rounding by the health care team. The team includes registered nurses (RN), advanced practice provider (APP, nurse practitioner and physician assistants) and hospitalist physician. Care at home is divided into 4 consecutive phases after initial hospitalization: (1) evaluation/planning, (2) acute, (3) recovery, and (4) rehabilitation. All patients are sent home with a RPM tablet used to obtain vital signs, send messages between patient and RN, \& perform video visits. The device is Bluetooth enabled and does not require WiFi or a phone line. All data obtained is automatically pulled into the electronic medical record. The RN uses a device which enables remote physical exams, i.e., obtain heart, lung and bowel sounds, pictures (wounds, lines, etc.) for review by APP/MD.

Treatment groups

30 Participants
are divided into 1 treatment group
Group A: Decompensated CirrhoticsOther 1 intervention

Trial outcomes

Primary outcomes

1

Number of participants enrolled into program

Time frame
Phase 1 Baseline
2

Reason for enrollment failure

Time frame
Phase 1 Baseline

Secondary outcomes

1

Number of participants with follow-up consultations during Phase 2

Time frame
During H@H program and up to and including 90 days after program completion
2

Number of participants with services utilized in the home during Phase 2

Time frame
During H@H program and up to and including 90 days after program completion
3

Number of participants with ED visits

ED visits, including repeat visits, will be tracked

Time frame
During H@H program and up to and including 90 days after program completion
4

Number of participants with rehospitalization

Time frame
During H@H program and up to and including 90 days after program completion

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Indiana University

Lead sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Collaborator

Source ClinicalTrials.gov
Apply now